Literature DB >> 16211871

Dendritic cell-based vaccines for cancer therapy.

A Grolleau, A Sloan, J J Mulé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16211871     DOI： 10.1007/0-387-27545-2_8

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  5 in total

1.  Impaired dendritic cell function in aging leads to defective antitumor immunity.

Authors:  Annabelle Grolleau-Julius; Erin K Harning; Lisa M Abernathy; Raymond L Yung
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 2.  Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient?

Authors:  Zeina Al-Mansour; Linda Pang; Venu Bathini
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

Review 3.  Mechanisms of murine dendritic cell antitumor dysfunction in aging.

Authors:  Annabelle Grolleau-Julius; Lisa Abernathy; Erin Harning; Raymond L Yung
Journal:  Cancer Immunol Immunother       Date:  2008-12-13       Impact factor: 6.968

4.  A comprehensive analysis of transfection-assisted delivery of iron oxide nanoparticles to dendritic cells.

Authors:  Shinji Toki; Reed A Omary; Kevin Wilson; John C Gore; R Stokes Peebles; Wellington Pham
Journal:  Nanomedicine       Date:  2013-06-06       Impact factor: 5.307

Review 5.  Antibody-Based Immunotherapeutic Strategies for the Treatment of Hematological Malignancies.

Authors:  Yizhao Han; Zhuojun Liu; Jia Liu; Weiqi Yan; Yuanshi Xia; Shuhua Yue; Jian Yu
Journal:  Biomed Res Int       Date:  2020-09-17       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.